(PSCH) Invesco S&P SmallCap Health - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1495 • Health

PSCH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment

The Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund (ETF) that tracks the performance of small-capitalization U.S. companies in the health care sector. The fund invests at least 90% of its total assets in the securities of the S&P SmallCap 600 Health Care Index, which is compiled, maintained, and calculated by S&P Dow Jones Indices, LLC. This index is designed to measure the performance of small-cap U.S. healthcare companies, as defined by the Global Industry Classification Standard (GICS).

The ETF provides exposure to a specific segment of the healthcare industry, focusing on smaller companies that may offer growth potential. It is designed for investors seeking targeted exposure to the small-cap healthcare sector within the U.S. equity market.

Ticker Symbol: PSCH Exchange: NASDAQ Type: ETF Country Origin: USA ETF Category: Health

3-Month Forecast: Based on the current technical and fundamental data, the ETF is expected to face moderate headwinds in the next three months. The SMA 20 and SMA 50 are above the current price, indicating potential resistance levels. The ATR suggests moderate volatility, and the average volume indicates lower liquidity compared to larger ETFs. The AUM of $171.86M reflects a moderate level of investor interest.

Given the current market conditions and the ETFs focus on small-cap healthcare companies, the 3-month outlook is neutral to slightly bearish. Investors should monitor the ETFs price action relative to its moving averages and be cautious of potential downside risks due to the technical resistance levels and lower trading volume.

Additional Sources for PSCH ETF

PSCH ETF Overview

Market Cap in USD 168m
Category Health
TER 0.29%
IPO / Inception 2010-04-07

PSCH ETF Ratings

Growth 5y 17.2%
Fundamental -
Dividend 28.5%
Rel. Strength Industry -9.26
Analysts -
Fair Price Momentum 36.59 USD
Fair Price DCF -

PSCH Dividends

Dividend Yield 12m 0.28%
Yield on Cost 5y 0.40%
Annual Growth 5y 447.72%
Payout Consistency 22.8%

PSCH Growth Ratios

Growth Correlation 3m -16.9%
Growth Correlation 12m 65.5%
Growth Correlation 5y -28.3%
CAGR 5y 7.01%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m 0.31
Alpha -11.14
Beta 0.95
Volatility 28.28%
Current Volume 7.2k
Average Volume 20d 11.2k
What is the price of PSCH stocks?
As of March 13, 2025, the stock is trading at USD 41.84 with a total of 7,247 shares traded.
Over the past week, the price has changed by -3.37%, over one month by -9.77%, over three months by -10.16% and over the past year by -1.88%.
Is Invesco S&P SmallCap Health a good stock to buy?
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap Health is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 17.16 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of March 2025 is 36.59. This means that PSCH is currently overvalued and has a potential downside of -12.55%.
Is PSCH a buy, sell or hold?
Invesco S&P SmallCap Health has no consensus analysts rating.
What are the forecast for PSCH stock price target?
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap Health will be worth about 41.2 in March 2026. The stock is currently trading at 41.84. This means that the stock has a potential downside of -1.65%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 41.2 -1.6%